Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Hepln-13

😃Good
Catalog No. T25492Cas No. 64369-13-7
Alias Hepln13, Hepln 13

Hepln-13 is a hepsin inhibitor that acts by hindering prostate cancer bone metastasis.

Hepln-13

Hepln-13

😃Good
Purity: 97.67%
Catalog No. T25492Alias Hepln13, Hepln 13Cas No. 64369-13-7
Hepln-13 is a hepsin inhibitor that acts by hindering prostate cancer bone metastasis.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$32In StockIn Stock
2 mg$46In StockIn Stock
5 mg$77In StockIn Stock
10 mg$128In StockIn Stock
25 mg$257In StockIn Stock
50 mg$383In StockIn Stock
100 mg$533In StockIn Stock
200 mg$737-In Stock
1 mL x 10 mM (in DMSO)$88In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:97.67%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Hepln-13 is a hepsin inhibitor that acts by hindering prostate cancer bone metastasis.
Targets&IC50
Hepsin:0.33 μM
In vitro
Hepln-13 (10 μM; 2 hours; 293 cells) inhibits cleavage[1].
In vivo
HepIn-13 displays dose-dependent inhibition of Hepsin overexpression-relevant prostate cancer phenotypes in LPB-Tag/PB-Hepsin mice and blocks prostate cancer metastasis in this animal model.
SynonymsHepln13, Hepln 13
Chemical Properties
Molecular Weight325.2
FormulaC17H13BrN2
Cas No.64369-13-7
SmilesBrc1ccc(cc1)C1Nc2cccc3cccc(N1)c23
Relative Density.1.444g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 60 mg/mL (184.5 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (6.15 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.0750 mL15.3752 mL30.7503 mL153.7515 mL
5 mM0.6150 mL3.0750 mL6.1501 mL30.7503 mL
10 mM0.3075 mL1.5375 mL3.0750 mL15.3752 mL
20 mM0.1538 mL0.7688 mL1.5375 mL7.6876 mL
50 mM0.0615 mL0.3075 mL0.6150 mL3.0750 mL
100 mM0.0308 mL0.1538 mL0.3075 mL1.5375 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Hepln-13 | purchase Hepln-13 | Hepln-13 cost | order Hepln-13 | Hepln-13 chemical structure | Hepln-13 in vivo | Hepln-13 in vitro | Hepln-13 formula | Hepln-13 molecular weight